Irritable bowel syndrome in adults: diagnosis and management : guidance (CG61)

Source:
National Institute for Health and Care Excellence - NICE
Publication date:
23 February 2008

Abstract

This guideline covers diagnosing and managing irritable bowel syndrome (IBS) in people aged 18 and over. It details how to accurately diagnose IBS, and aims to improve the quality of life for adults with IBS by promoting effective management using dietary and lifestyle advice, pharmacological therapy and referral for psychological interventions.

In April 2017, recommendation 1.1.1.2 was updated in line with more recent guidance on recognition and referral for suspected cancer. This recommendation is dated [2017]. Recommendation 1.1.1.3 was removed as it was no longer needed after the changes to recommendation 1.1.1.2.

Recommendations

This guideline includes recommendations on:

Who is it for?

  • Healthcare professionals
  • Commissioners and providers
  • People with suspected or confirmed IBS and their families and carers

Is this guideline up to date?

Guideline checked February 2017. We found no new evidence that affects the recommendations in this guideline.

Guideline development process

How we develop NICE guidelines

This guideline was previously called irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care.